首页 > 产品目录 > 信号通路 > PI3K/Akt/mTOR > PI3K inhibitor > 匹替利司 | 2-(1H-吲唑-4-基)-6-[[4-(甲基磺酰基)-1-哌嗪基]甲基]-4-(4-吗啉基)噻吩并[3,2-d]嘧啶; 匹替利司

匹替利司 | 2-(1H-吲唑-4-基)-6-[[4-(甲基磺酰基)-1-哌嗪基]甲基]-4-(4-吗啉基)噻吩并[3,2-d]嘧啶; 匹替利司

ChemLeader 98+%

Pictilisib | GDC-0941 | RG7321

产品编号:CL2026 CAS No.:957054-30-7 MDLNo: 分子式:C23H27N7O3S2 分子量:513.64
规格 库存 目录价 会员专享价 数量

暂无牌价信息,您可以发送询价,我们会尽快给你回复。

化学品安全说明书(MSDS)

下载MSDS
  • 基本信息
  • 相关文档
  • 产品详情
  • 相关文献
基本信息
英文名称 Pictilisib | GDC-0941 | RG7321
中文名称匹替利司 | 2-(1H-吲唑-4-基)-6-[[4-(甲基磺酰基)-1-哌嗪基]甲基]-4-(4-吗啉基)噻吩并[3,2-d]嘧啶; 匹替利司
CAS号957054-30-7
分子式C23H27N7O3S2
分子量513.64
外观White to yellow powder
储存条件Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
产品详情

It is currently being investigated for its potential in treating various types of cancer, including solid tumors, breast cancer, and non-Hodgkin’s lymphoma. Pictilisib works by targeting the PI3K pathway, which is often deregulated in cancer cells, leading to uncontrolled cell growth and survival.


相关产品
抱歉,暂时没有相关产品
在线客服
小德
021-58180488
小立
021-58180488
在线服务时间: 工作日 9:00-18:00